These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 23069256)

  • 1. Down-regulation of Toll-like receptor 7 expression in hepatitis-virus-related human hepatocellular carcinoma.
    Lin KJ; Lin TM; Wang CH; Liu HC; Lin YL; Eng HL
    Hum Pathol; 2013 Apr; 44(4):534-41. PubMed ID: 23069256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TLR3 signaling in a hepatoma cell line is skewed towards apoptosis.
    Khvalevsky E; Rivkin L; Rachmilewitz J; Galun E; Giladi H
    J Cell Biochem; 2007 Apr; 100(5):1301-12. PubMed ID: 17243100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis virus infection affects DNA methylation in mice with humanized livers.
    Okamoto Y; Shinjo K; Shimizu Y; Sano T; Yamao K; Gao W; Fujii M; Osada H; Sekido Y; Murakami S; Tanaka Y; Joh T; Sato S; Takahashi S; Wakita T; Zhu J; Issa JP; Kondo Y
    Gastroenterology; 2014 Feb; 146(2):562-72. PubMed ID: 24184133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired expression and function of toll-like receptor 7 in hepatitis C virus infection in human hepatoma cells.
    Chang S; Kodys K; Szabo G
    Hepatology; 2010 Jan; 51(1):35-42. PubMed ID: 19821521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive value of expression and promoter hypermethylation of XAF1 in hepatitis B virus-associated hepatocellular carcinoma treated with transplantation.
    Zhang F; Wu LM; Zhou L; Chen QX; Xie HY; Feng XW; Zheng SS
    Ann Surg Oncol; 2008 Dec; 15(12):3494-502. PubMed ID: 18830757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression profiling of hepatitis B- and hepatitis C-related hepatocellular carcinoma using graphical Gaussian modeling.
    Ueda T; Honda M; Horimoto K; Aburatani S; Saito S; Yamashita T; Sakai Y; Nakamura M; Takatori H; Sunagozaka H; Kaneko S
    Genomics; 2013 Apr; 101(4):238-48. PubMed ID: 23485556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of furin by interferon-γ and the impact on hepatitis B virus antigen biosynthesis in human hepatocytes.
    Wu JF; Hsu HY; Ni YH; Chen HL; Wu TC; Chang MH
    Am J Pathol; 2012 Jul; 181(1):19-25. PubMed ID: 22634051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of fetal promoters of insulinlike growth factors II gene in hepatitis C virus-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
    Nardone G; Romano M; Calabrò A; Pedone PV; de Sio I; Persico M; Budillon G; Bruni CB; Riccio A; Zarrilli R
    Hepatology; 1996 Jun; 23(6):1304-12. PubMed ID: 8675143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific gene-expression profiles of noncancerous liver tissue predict the risk for multicentric occurrence of hepatocellular carcinoma in hepatitis C virus-positive patients.
    Okamoto M; Utsunomiya T; Wakiyama S; Hashimoto M; Fukuzawa K; Ezaki T; Hanai T; Inoue H; Mori M
    Ann Surg Oncol; 2006 Jul; 13(7):947-54. PubMed ID: 16788756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-hepatitis B virus (HBV) response of imiquimod based toll like receptor 7 ligand in hbv-positive human hepatocelluar carcinoma cell line.
    Das D; Sengupta I; Sarkar N; Pal A; Saha D; Bandopadhyay M; Das C; Narayan J; Singh SP; Chakrabarti S; Chakravarty R
    BMC Infect Dis; 2017 Jan; 17(1):76. PubMed ID: 28088184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased PADI4 mRNA association with global hypomethylation in hepatocellular carcinoma during HBV exposure.
    Zhang C; Fan L; Fan T; Wu D; Gao L; Ling Y; Zhu J; Li R; Wei L
    Cell Biochem Biophys; 2013 Mar; 65(2):187-95. PubMed ID: 22907585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TNF-α Induced by Hepatitis C Virus via TLR7 and TLR8 in Hepatocytes Supports Interferon Signaling via an Autocrine Mechanism.
    Lee J; Tian Y; Chan ST; Kim JY; Cho C; Ou JH
    PLoS Pathog; 2015 May; 11(5):e1004937. PubMed ID: 26023919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis.
    Nomoto S; Kanda M; Okamura Y; Nishikawa Y; Qiyong L; Fujii T; Sugimoto H; Takeda S; Nakao A
    Ann Surg Oncol; 2010 Mar; 17(3):923-32. PubMed ID: 19898900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in glucose-6-phosphate dehydrogenase expression results in altered behavior of HBV-associated liver cancer cells.
    Hu H; Ding X; Yang Y; Zhang H; Li H; Tong S; An X; Zhong Q; Liu X; Ma L; Liu Q; Liu B; Lu Z; Zhang D; Hu P; Ren H
    Am J Physiol Gastrointest Liver Physiol; 2014 Sep; 307(6):G611-22. PubMed ID: 24994855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocellular carcinoma with persistent hepatitis B virus infection shows unusual downregulation of Ras expression and differential response to Ras mediated signaling.
    Bose S; Sakhuja P; Bezawada L; Agarwal AK; Kazim SN; Khan LA; Sarin SK; Ramakrishna G
    J Gastroenterol Hepatol; 2011 Jan; 26(1):135-44. PubMed ID: 21175807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of pathways associated with hepatitis B- and C-infected hepatocellular carcinoma using pathway-based class discrimination method.
    Lee SY; Song KH; Koo I; Lee KH; Suh KS; Kim BY
    Genomics; 2012 Jun; 99(6):347-54. PubMed ID: 22564472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of interferon gamma receptor expression on the mechanism of escape from host immune surveillance in hepatocellular carcinoma.
    Nagao M; Nakajima Y; Kanehiro H; Hisanaga M; Aomatsu Y; Ko S; Tatekawa Y; Ikeda N; Kanokogi H; Urizono Y; Kobayashi T; Shibaji T; Kanamura T; Ogawa S; Nakano H
    Hepatology; 2000 Sep; 32(3):491-500. PubMed ID: 10960440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SiRNA-targeted carboxypeptidase D inhibits hepatocellular carcinoma growth.
    Jin T; Fu J; Feng XJ; Wang SM; Huang X; Zhu MH; Zhang SH
    Cell Biol Int; 2013 Sep; 37(9):929-39. PubMed ID: 23589395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-122 inhibits viral replication and cell proliferation in hepatitis B virus-related hepatocellular carcinoma and targets NDRG3.
    Fan CG; Wang CM; Tian C; Wang Y; Li L; Sun WS; Li RF; Liu YG
    Oncol Rep; 2011 Nov; 26(5):1281-6. PubMed ID: 21725618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B virus DNA integration in hepatocellular carcinoma after interferon-induced disappearance of hepatitis C virus.
    Tamori A; Nishiguchi S; Shiomi S; Hayashi T; Kobayashi S; Habu D; Takeda T; Seki S; Hirohashi K; Tanaka H; Kubo S
    Am J Gastroenterol; 2005 Aug; 100(8):1748-53. PubMed ID: 16086711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.